12 August 2024: The Board of Directors ("Board") hereby calls for an
Extraordinary General Meeting of Aker BioMarine ASA (the "Company") at 10.00 CET
on 3 September 2024.

Reference is made to stock exchange notification sent by the Company on July
3rd, 2024. In order to execute payment of dividend as planned, the Board
proposes that the general meeting, on the basis of the approved annual accounts
for 2023, authorizes the Board to resolve distribution of dividends. The
authorization shall be valid until 31 December 2024.

The General Meeting will be held as a digital event. Link for the meeting and
further information regarding participation is available at the Company's
website www.akerbiomarine.com/EGM. 

No pre-registration is needed for attending online, but attendees must be logged
in before the meeting starts. Proxy, proxy with voting instructions or advance
votes are asked to be sent in by 30 
August 2024 at 4:00 pm.

The notice and proxy forms for the Extraordinary General Meeting is attached.



For further information, please contact 
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820 
Email:  Christopher.vinter@akerbiomarine.com  
 
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for consumer health and wellness as
well as animal nutrition. The company has a strong position in its industry and
is the world's leading supplier of krill, the natural, powerful and health
promoting source of nutrients from the pristine waters of Antarctica. Aker
BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available
at www.akerbiomarine.com.